Acacetin inhibits inflammation by blocking MAPK/NF-κB pathways and NLRP3 inflammasome activation.

Authors:
Bu J; Mahan Y; Zhang S; Wu X; Zhang X and 2 more

Journal:
Front Pharmacol

Publication Year: 2024

DOI:
10.3389/fphar.2024.1286546

PMCID:
PMC10883387

PMID:
38389927

Journal Information

Full Title: Front Pharmacol

Abbreviation: Front Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by grants from “Tianshan Youth Project” of Program for Fostering Excellent Young Talents in Science and Technology of Xinjiang Uygur Autonomous Region (Grant No. 2020Q046), Natural Science Foundation of Xinjiang Uygur Autonomous Region (Grant No. 2020D01C095), and Program for Fostering Excellent Young Talents in Science and Technology of Urumqi, China to JB and Foundation of People’s Hospital of Xinjiang Uygur Autonomous Region (Grant No. 20210110) to YM"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025